Anzeige
Mehr »
Login
Samstag, 02.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Technischer Ausbruch: Diese Kupferaktie ist in den letzten 52 Wochen um 300 % gestiegen! Der Durchbruch läuft!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3D495 | ISIN: CA13765U2002 | Ticker-Symbol: 8CB0
Frankfurt
01.11.24
08:10 Uhr
0,450 Euro
+0,018
+4,17 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
CANNARA BIOTECH INC Chart 1 Jahr
5-Tage-Chart
CANNARA BIOTECH INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,4100,49613:04

Aktuelle News zur CANNARA BIOTECH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
16.08.Cannara Biotech Inc (2): Cannara Biotech talks up July market share1
16.08.Cannara Biotech Inc.: Cannara Biotech Achieves its Highest National Market Share of 3.2% in July 2024 and Announces Investor Webcast Scheduled for August 20, 202480MONTREAL, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis and...
► Artikel lesen
23.07.Cannara Biotech Inc (2): Cannara Biotech earns $2.02-million in Q31
23.07.Cannara Biotech Reports 6% YoY Drop In Q3 Gross Profit, 22% Revenue Increase As It Enhances Sales Force And Infrastructure1
23.07.Cannara Biotech GAAP EPS of C$0.02, revenue of C$19.5M1
23.07.Cannara Biotech Inc.: Cannara Biotech Reports Q3 2024 Financial Results308Gross cannabis revenues before excise taxes increased to $26.2 million in Q3 2024 from $20.6 million in Q3 2023, a $5.6 million or 27.6%, increase. Total revenues, net of excise taxes, increased to...
► Artikel lesen
29.04.Cannara Biotech Inc.: Cannara Biotech Reports Q2 2024 Financial Results371Net revenue, increased to $19.7 million in Q2 2024 from $13.0 million in Q2 2023, a 51.0% increase.Gross profit, before fair value adjustments, increased to $7.1 million in Q2 2024 from $4.0 million...
► Artikel lesen
30.01.Cannara Biotech Inc.: Cannara Biotech Announces Record-Breaking Q1 2024 Results: Continued Robust Growth and Market Expansion277Record Q1 net revenues of $19.5 million, representing an 89% increase compared to the $10.3 million of net revenues generated in Q1 2023Q1 operating income of $3.4 million, representing an 201% increase...
► Artikel lesen
07.12.23Cannara Biotech Inc.: Cannara Biotech Reports Fourth Quarter and 2023 Fiscal Year Results: Record Growth and Profitability Continues400Record Q4 and year end net revenues of $18.3 million and $57.6 million, representing a 53% and 60% increase compared to the same periods of 2022 Sequentially, Q4 showed significant growth over Q3 2023...
► Artikel lesen
9 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1